| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Year Ended 31 January 2025 |
| for |
| Taylors Organex Limited |
| REGISTERED NUMBER: |
| Unaudited Financial Statements |
| for the Year Ended 31 January 2025 |
| for |
| Taylors Organex Limited |
| Taylors Organex Limited (Registered number: 00755431) |
| Contents of the Financial Statements |
| for the year ended 31 January 2025 |
| Page |
| Company Information | 1 |
| Statement of Financial Position | 2 |
| Notes to the Financial Statements | 4 |
| Taylors Organex Limited |
| Company Information |
| for the year ended 31 January 2025 |
| DIRECTORS: |
| SECRETARY: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Datum House |
| Electra Way |
| Crewe |
| Cheshire |
| CW1 6ZF |
| Taylors Organex Limited (Registered number: 00755431) |
| Statement of Financial Position |
| 31 January 2025 |
| 2025 | 2024 |
| Notes | £ | £ |
| FIXED ASSETS |
| Tangible assets | 5 |
| Investments | 6 |
| Investment property | 7 |
| CURRENT ASSETS |
| Debtors | 8 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 9 | ( |
) | ( |
) |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
10 |
( |
) |
( |
) |
| PROVISIONS FOR LIABILITIES | 14 | ( |
) | ( |
) |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Capital redemption reserve |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Taylors Organex Limited (Registered number: 00755431) |
| Statement of Financial Position - continued |
| 31 January 2025 |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements |
| for the year ended 31 January 2025 |
| 1. | STATUTORY INFORMATION |
| Taylors Organex Limited ('The Company') is a holding company. |
| The company is a private company limited by shares and is incorporated in England and Wales. The address of the principal place of business and of the registered office is Unit 1 Alexandra Business Park, Gresty Lane, Crewe, Cheshire, CW2 5DD. The registered number can be found on the Company Information page. |
| The presentation currency of the financial statements is the Pound Sterling (£). Monetary amounts in these financial statements are rounded to the nearest £. |
| 2. | STATEMENT OF COMPLIANCE |
| 3. | ACCOUNTING POLICIES |
| Summary of significant accounting policies |
| The principal accounting policies applied in the preparation of these financial statements are set out below. |
| These policies have been consistently applied to all years presented, unless otherwise stated. |
| Basis of preparation |
| The financial statements are prepared on the going concern basis under the historical cost convention and comply with the United Kingdom Accounting Standards and Companies Act 2006. |
| Going concern |
| No material uncertainties that may cast significant doubt about the ability of the company to continue as a going concern have been identified by the directors. |
| Notwithstanding any uncertainties the directors consider it appropriate to prepare the financial statements on the going concern basis. |
| Turnover |
| Revenue (described as turnover) represents invoiced management charges, excluding value added tax. |
| Tangible fixed assets |
| Tangible fixed assets are stated at historical cost less accumulated depreciation and accumulated impairment losses plus any revaluations. Cost includes costs directly attributable to making the asset capable of operating as intended. |
| Depreciation is provided at the following annual rates so as to write off their cost less residual amounts over their estimated useful economic lives. Assets are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognised for the amount by which the assets carrying amount exceeds its recoverable amount. |
| Fixtures and equipment | - 25% on reducing balance |
| The residual values and useful lives of assets are reviewed and adjusted if appropriate at each reporting period end date. |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 3. | ACCOUNTING POLICIES - continued |
| Investment property |
| Investment property is shown at fair value, the fair value is reviewed annually by the director. Any aggregate surplus or deficit arising from changes in the fair value in the year is recognised in the profit or loss within the Statement of Comprehensive Income. The cumulative fair value surplus on the investment property is highlighted in the notes to the financial statements as non-distributable reserves. Rentals are recognised on a straight line basis over the period of the lease or to the date of the next rent review. Net rental income after direct costs is included in other operating income. The company's freehold property has been treated as an investment property as of 31 January 2023. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the end of the financial year. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the end of the financial year. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Other income |
| Rentals are recognised on a straight line basis over the period of the lease or to the date of the next rent review. Rental income received is included in other operating income. |
| Impairment of assets |
| Assets not measured at fair value are reviewed for any indications that the asset may be impaired at each statement of financial position date. If such indications exists the recoverable amount of the asset or the assets cash generating unit is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease. |
| Any losses arising from impairment are recognised in the Statement of Comprehensive Income under the appropriate heading. |
| 4. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 5. | TANGIBLE FIXED ASSETS |
| Fixtures |
| and |
| equipment |
| £ |
| COST OR VALUATION |
| Additions |
| At 31 January 2025 |
| DEPRECIATION |
| Charge for year |
| At 31 January 2025 |
| NET BOOK VALUE |
| At 31 January 2025 |
| 6. | FIXED ASSET INVESTMENTS |
| Unlisted |
| investments |
| £ |
| COST |
| At 1 February 2024 |
| Disposals | ( |
) |
| At 31 January 2025 |
| NET BOOK VALUE |
| At 31 January 2025 |
| At 31 January 2024 |
| The company's investments at the Statement of Financial Position date in the share capital of companies include the following: |
| Registered office: Unit 1, Alexandra Business Park, Gresty Lane, Crewe, Cheshire, CW2 5DD |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2025 | 2024 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 7. | INVESTMENT PROPERTY |
| Total |
| £ |
| FAIR VALUE |
| At 1 February 2024 |
| Additions |
| At 31 January 2025 |
| NET BOOK VALUE |
| At 31 January 2025 |
| At 31 January 2024 |
| Investment property was valued on an open market basis on 17 January 2023 by Butters John Bee, an independent firm. |
| Fair value at 31 January 2025 is represented by: |
| £ |
| Valuation in 2023 | 620,000 |
| Cost | 29,092 |
| 649,092 |
| 8. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Amounts owed by group undertakings |
| Other debtors |
| Amounts owed by group undertakings and related parties are unsecured, interest free and repayable on demand. |
| 9. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Bank loans and overdrafts (see note 11) |
| Trade creditors |
| Taxation and social security |
| Other creditors |
| Amounts owed to group undertakings are unsecured, interest free and repayable on demand. |
| 10. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2025 | 2024 |
| £ | £ |
| Bank loans (see note 11) |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 10. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued |
| 2025 | 2024 |
| £ | £ |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans more than 5 years | 88,904 | 115,734 |
| 11. | LOANS |
| An analysis of the maturity of loans is given below: |
| 2025 | 2024 |
| £ | £ |
| Amounts falling due within one year or on demand: |
| Bank loans |
| Amounts falling due between one and two years: |
| Bank loans - 1-2 years |
| Amounts falling due between two and five years: |
| Bank loans - 2-5 years |
| Amounts falling due in more than five years: |
| Repayable by instalments |
| Bank loans more than 5 years | 88,904 | 115,734 |
| 12. | LEASING AGREEMENTS |
| The company had outstanding commitments in respect of operating leases as at 31 January 2025 of £46,272 (2024: £7,315). |
| Minimum lease payments receivable fall due as follows: |
| Non-cancellable operating |
| leases |
| 2025 | 2024 |
| £ | £ |
| Within one year | 43,850 | 27,000 |
| Between one and five years | 91,950 | 34,700 |
| 135,800 | 61,700 |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 13. | SECURED DEBTS |
| The following secured debts are included within creditors: |
| 2025 | 2024 |
| £ | £ |
| Bank loans |
| The bank loans and overdraft are secured by a debenture over the company's assets and cross-guarantee given by the company's subsidiary undertaking. |
| 14. | PROVISIONS FOR LIABILITIES |
| 2025 | 2024 |
| £ | £ |
| Deferred tax | 103,878 | 103,098 |
| Deferred |
| tax |
| £ |
| Balance at 1 February 2024 |
| Charge to Income Statement during year |
| Balance at 31 January 2025 |
| 15. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES |
| The following advances and credits to directors subsisted during the years ended 31 January 2025 and 31 January 2024: |
| 2025 | 2024 |
| £ | £ |
| Balance outstanding at start of year |
| Amounts advanced |
| Amounts repaid | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year |
| Taylors Organex Limited (Registered number: 00755431) |
| Notes to the Financial Statements - continued |
| for the year ended 31 January 2025 |
| 16. | RELATED PARTY DISCLOSURES |
| Transactions with related parties during the year and balances outstanding at the end of the reporting period were as follows: |
| Entities over which the company has control: |
| 2025 | 2024 |
| £ | £ |
| Management fees receivable | 48,000 | 34,200 |
| Rent receivable | 19,900 | 18,850 |
| Utilities recharged | 11,241 | 15,220 |
| Dividends receivable | 44,050 | 27,600 |
| Amounts owed by entities | 86,064 | 76,824 |
| Entities in which the directors have an interest: |
| 2025 | 2024 |
| £ | £ |
| Rent receivable | 3,360 | 12,700 |
| Amounts due by entities | 200 | 802 |
| 17. | NON-DISTRIBUTABLE RESERVES |
| Included within retained earnings is an amount of £391,781 (2024: £391,781) which is non-distributable. |